New York — October 22, 2026 — We are excited to share two important updates.
First, following a scheduled safety review, the clinical trial's Safety Review Committee authorized the continued enrollment and treatment of the remaining participants in the first cohort.
Second, we are happy to announce the activation of our second clinical trial site at the University of California San Francisco (UCSF) Benioff Children's Hospital in Oakland, California. Both clinical trial sites are currently actively enrolling candidate participants, and the trial enrollment is progressing as planned.
Information pertaining to the clinical trial will be available on ClinicalTrials.gov
About the FOXG1 Research Foundation
The FOXG1 Research Foundation is a global, parent-led nonprofit organization founded in 2017 with the mission to improve the lives of every person and family impacted by FOXG1 syndrome. FRF advances research, builds community, and is pioneering a new blueprint for rare disease drug development—accelerating the path to life-changing therapies for children worldwide. Learn more at FOXG1Research.org.
Media Contact press@foxg1research.org